Raymond S. Douglas

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Teprotumumab and the Evolving Therapeutic Landscape in Thyroid Eye Disease”.

Teprotumumab and the Evolving Therapeutic Landscape in Thyroid Eye Disease

The Journal of Clinical Endocrinology & Metabolism(2022)10.1210/clinem/dgac168

N/A

0DataRank · unranked

28 citations

Raymond S. Douglas, Chrysoula Dosiou, Andrea L. Kossler

Teprotumumab-Related Adverse Events in Thyroid Eye Disease

Ophthalmology(2023)10.1016/j.ophtha.2023.10.018

N/A

0DataRank · unranked

36 citations

Linus Amarikwa, Connie M. Sears, Kevin D. Clauss, Raneem D. Rajjoub, Julia Kang +9 more

Teprotumumab for the Treatment of Recalcitrant Thyroid Eye Disease

Ophthalmic Plastic and Reconstructive Surgery(2023)10.1097/iop.0000000000002564

N/A

0DataRank · unranked

18 citations

Linus Amarikwa, Brandon Pham, Connie M. Sears, Kevin D. Clauss, Bradford W. Lee +9 more

Reply

Ophthalmology(2024)10.1016/j.ophtha.2024.01.003

N/A

0DataRank · unranked

0 citations

Linus Amarikwa, Connie M. Sears, Kevin D. Clauss, Raneem D. Rajjoub, Julia Kang +9 more